pharma operations – Page 63

Uncontrolled parameter limits during validation lifecycle – how to prevent repeat validation failures

Addressing Uncontrolled Parameter Limits in the Validation Lifecycle to Prevent Repeat Failures The pharmaceutical manufacturing industry is meticulously regulated, necessitating stringent adherence to Good Manufacturing Practices (GMP) throughout all operational…

CSV not aligned to actual use during change control review – documentation pitfalls that trigger 483 observations

Documentation Gaps in Change Control Reviews Leading to CSV Misalignment and 483 Observations In today’s fast-paced pharmaceutical environment, the need for stringent compliance with Good Manufacturing Practices (GMP) has never…

Revalidation not triggered after change during requalification planning – regulatory deficiency analysis and remediation roadmap

Analysis of Regulatory Deficiencies Related to Untriggered Revalidation Following Change in Requalification Planning In pharmaceutical operations, the requirement to trigger revalidation upon certain changes is critical for maintaining compliance and…

CSV not aligned to actual use during system upgrades – how to rebuild the evidence package for inspectors

“`html Addressing CSV Misalignment During System Upgrades: Building Your Evidence Package for Inspection In the highly regulated pharmaceutical environment, computerized systems play a vital role, making Computerized System Validation (CSV)…

Traceability matrix gaps during tech transfer validation – regulatory deficiency analysis and remediation roadmap

Understanding and Addressing Traceability Matrix Gaps During Tech Transfer Validation Traceability is a foundational aspect of tech transfer validation in pharmaceutical manufacturing, ensuring that processes align with regulatory requirements and…

Incomplete impact assessment during inspection readiness – CAPA and revalidation plan with timelines

Addressing Incomplete Impact Assessments During Inspection Readiness: A Comprehensive CAPA and Revalidation Plan In the pharmaceutical manufacturing industry, ensuring compliance during regulatory inspections is crucial. One common issue that can…

PPQ acceptance criteria not met during requalification planning – documentation pitfalls that trigger 483 observations

Requalification Planning: Addressing Issues with PPQ Acceptance Criteria and Documentation Shortcomings The pharmaceutical industry is under constant scrutiny to uphold stringent quality standards, especially during requalification planning processes. It is…

Periodic review overdue during inspection readiness – how to rebuild the evidence package for inspectors

How to Address Overdue Periodic Reviews in Inspection Readiness In pharmaceutical manufacturing, maintaining compliant documentation is crucial for successful inspections by regulatory authorities such as the FDA, EMA, and MHRA.…

Equipment qualification incomplete during tech transfer validation – risk-based validation strategy aligned to FDA/EMA

Addressing Incomplete Equipment Qualification in Tech Transfer Validation: A Risk-Based Approach In a highly regulated environment, equipment qualification during tech transfer validation is paramount for ensuring product quality and compliance.…

Equipment qualification incomplete during inspection readiness – how to rebuild the evidence package for inspectors

Rebuilding the Evidence Package for Equipment Qualification Incomplete During Inspection Readiness In the highly regulated world of pharmaceutical manufacturing, the integrity of equipment qualification is paramount to ensuring compliance with…

Periodic review overdue during validation lifecycle – regulatory deficiency analysis and remediation roadmap

Assessing and Remediating Periodic Review Overdue During the Validation Lifecycle The pharmaceutical industry’s stringent regulatory framework necessitates regular evaluations within the validation lifecycle. When periodic reviews are overdue, the implications…

Inadequate worst-case justification during tech transfer validation – regulatory deficiency analysis and remediation roadmap

Regulatory Deficiencies in Tech Transfer Validation: Addressing Inadequate Worst-Case Justification In pharmaceutical manufacturing, the tech transfer process is a critical phase that ensures product consistency and quality as production shifts…